Eisai partners with Sato Pharma to commercialise anti-fungal agent fosravuconazole in Asia, Oceania BSA bureau
Source link : https://news.google.com/rss/articles/CBMi4wFBVV95cUxNWkg2TmRjdEVmbGo1UVJCMDNIeVozRHdaTnBIZUJLcXVjWmN2VjkzR1o0aWd1QmppZElwS0RzWXhHcVd2bF92S3FRZ0wzNEM1WDBfQXRlcEZvRWJHN2VnczVmbXJIdU5SWFVXd3BMTktoRGktYjVtalhWaFZyRlhDU1EwOEtDYm5PU3A3R3IyQ21RcVNYbDlWaVpPZmZVOFlSbEVVSzQwSEktaHNtdE15dkl3WGVOeTZhXzAyNHAxdDB0c2JkTnM5cG9WY1ZMcDllZThVeV9teG51N29PR1BGTW1Ebw?oc=5
Author :
Publish date : 2024-07-23 04:04:57
Copyright for syndicated content belongs to the linked Source.
